Repligen
RGEN
#1738
Rank
โ‚น1.144 T
Marketcap
โ‚น18,027
Share price
2.48%
Change (1 day)
34.81%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น79.83 Billion

According to Repligen 's latest financial reports the company's total liabilities are โ‚น79.83 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น75.72 B3.01%
2024-12-31โ‚น73.51 B1.93%
2023-12-31โ‚น72.12 B40.37%
2022-12-31โ‚น51.37 B13.48%
2021-12-31โ‚น45.27 B65.64%
2020-12-31โ‚น27.33 B12.62%
2019-12-31โ‚น24.27 B118.23%
2018-12-31โ‚น11.12 B14.61%
2017-12-31โ‚น9.70 B18.85%
2016-12-31โ‚น8.16 B423.06%
2015-12-31โ‚น1.56 B48.72%
2014-12-31โ‚น1.04 B15.11%
2013-12-31โ‚น0.91 B29.24%
2012-12-31โ‚น0.70 B
2011-03-31โ‚น0.23 B-2.07%
2010-03-31โ‚น0.23 B0.97%
2009-03-31โ‚น0.23 B23.42%
2008-03-31โ‚น0.18 B24.18%
2007-03-31โ‚น0.15 B7.59%
2006-03-31โ‚น0.14 B-1.61%
2005-03-31โ‚น0.14 B35.72%
2004-03-31โ‚น0.10 B-0.37%
2003-03-31โ‚น0.10 B-18.04%
2002-03-31โ‚น0.13 B122.07%
2001-03-31โ‚น58.62 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚น11.014 T 13,696.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น5.749 T 7,102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น10.458 T 13,000.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น6.221 T 7,692.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น7.51 B-90.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น109.18 B 36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น158.63 B 98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น45.57 B-42.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น514.51 B 544.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น442.30 B 454.03%๐Ÿ‡บ๐Ÿ‡ธ USA